|
KMID : 0882420140870060686
|
|
Korean Journal of Medicine
2014 Volume.87 No. 6 p.686 ~ p.689
|
|
|
Dyslipidemia Treatment in Diabetes Mellitus Patients
|
|
Kim Sung-Rae
|
|
|
Abstract
|
|
|
|
Cardiovascular disease (CVD) is the major cause of mortality and morbidity in patients with type 2 diabetes mellitus. The increased risk of CVD in subjects with type 2 diabetes mellitus involves multiple factors, including hypertension, smoking, albuminuria, and hypercholesterolemia. Of these, hypercholesterolemia is amenable to intervention. A large body of research ranging from molecular to population studies indicates that elevated low-density-lipoprotein cholesterol (LDL-C) is a major predictor of CVD, including in the population with diabetes. Despite available therapies and increased attention to hypercholesterolemia, many patients fail to achieve the LDL-C goals. A patient-tailored approach to dyslipidemia therapy, as determined by baseline LDL-C levels, is an effective strategy for achieving target LDL-C levels.
|
|
|
KEYWORD
|
|
|
Type 2 diabetes mellitus, Cardiovascular disease, Hypercholesterolemia, LDL cholesterol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|